MICAgen Mice Recapitulate the Highly Restricted but Activation-Inducible Expression of the Paradigmatic Human NKG2D Ligand MICA

Autor Kim, Younghoon, Born, Christina, Bléry, Mathieu, Steinle, Alexander
Vydáno v Front Immunol (2020)

Analysis of an Ethylnitrosourea-generated Mouse Mutation Defines a Cell Intrinsic Role of Nuclear Factor κB2 in Regulating Circulating B Cell Numbers

Autor Miosge, Lisa A., Blasioli, Julie, Blery, Mathieu, Goodnow, Christopher C.
Vydáno 2002

Essential role of membrane cholesterol in accelerated BCR internalization and uncoupling from NF-κB in B cell clonal anergy

Autor Bléry, Mathieu, Tze, Lina, Miosge, Lisa A., Jun, Jesse E., Goodnow, Christopher C.
Vydáno 2006

The paired Ig-like receptor PIR-B is an inhibitory receptor that recruits the protein-tyrosine phosphatase SHP-1

Autor Bléry, Mathieu, Kubagawa, Hiromi, Chen, Ching-Cheng, Vély, Frédéric, Cooper, Max D., Vivier, Eric
Vydáno 1998

The Role of Natural Killer Cells in Sepsis

Autor Chiche, Laurent, Forel, Jean-Marie, Thomas, Guillemette, Farnarier, Catherine, Vely, Fréderic, Bléry, Mathieu, Papazian, Laurent, Vivier, Eric
Vydáno 2011

Genetic and antibody-mediated reprogramming of natural killer cell missing-self recognition in vivo

Autor Sola, Caroline, André, Pascale, Lemmers, Céline, Fuseri, Nicolas, Bonnafous, Cécile, Bléry, Mathieu, Wagtmann, Nicolai R., Romagné, François, Vivier, Eric, Ugolini, Sophie
Vydáno 2009

Anti-tumoral efficacy of therapeutic human anti-KIR antibody (Lirilumab/BMS-986015/IPH2102) in a preclinical xenograft tumor model

Autor Sola, Caroline, Chanuc, Fabien, Thielens, Ariane, Fuseri, Nicolas, Morel, Yannis, Bléry, Mathieu, André, Pascale, Vivier, Eric, Graziano, Robert, Romagne, Francois, Bonnafous, Cécile
Vydáno 2013

Effects of anti-NKG2A antibody administration on leukemia and normal hematopoietic cells

Autor Ruggeri, Loredana, Urbani, Elena, André, Pascale, Mancusi, Antonella, Tosti, Antonella, Topini, Fabiana, Bléry, Mathieu, Animobono, Lucia, Romagné, François, Wagtmann, Nicolai, Velardi, Andrea
Vydáno v Haematologica (2016)

Targeting MICA with therapeutic antibodies for the treatment of cancer

Autor Bonnafous, Cécile, Peri, Valentine, Trichard, Sylvia, Perrot, Ivan, Cornen, Stéphanie, Thielens, Ariane, Breso, Violette, Morel, Yannis, Rossi, Benjamin, Paturel, Carine, Gauthier, Laurent, Bléry, Mathieu
Vydáno 2013

Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA/B and NKG2A targeting for cancer treatment

Autor Courau, Tristan, Bonnereau, Julie, Chicoteau, Justine, Bottois, Hugo, Remark, Romain, Assante Miranda, Laura, Toubert, Antoine, Blery, Mathieu, Aparicio, Thomas, Allez, Matthieu, Le Bourhis, Lionel
Vydáno v J Immunother Cancer (2019)

Novel therapeutic and diagnostic antibodies against KIR3DL2, a unique tumor antigen overexpressed on subtypes of T cell lymphomas

Autor Marie-Cardine, Anne, Viaud, Nicolas, Dujardin, Arnaud, Rachel, Joly, Granier, Nathalie, Gauthier, Laurent, Bonnafous, Cecile, Blery, Mathieu, Paturel, Carine, Bensussan, Armand, Bagot, Martine, Sicard, Helene
Vydáno 2013

Inhibition of IgE-mediated mast cell activation by the paired Ig-like receptor PIR-B

Autor Uehara, Takahiro, Bléry, Mathieu, Kang, Dong-Won, Chen, Ching-Cheng, Ho, Le Hong, Gartland, G. Larry, Liu, Fu-Tong, Vivier, Eric, Cooper, Max D., Kubagawa, Hiromi
Vydáno 2001

High mTOR activity is a hallmark of reactive natural killer cells and amplifies early signaling through activating receptors

Autor Marçais, Antoine, Marotel, Marie, Degouve, Sophie, Koenig, Alice, Fauteux-Daniel, Sébastien, Drouillard, Annabelle, Schlums, Heinrich, Viel, Sébastien, Besson, Laurie, Allatif, Omran, Bléry, Mathieu, Vivier, Eric, Bryceson, Yenan, Thaunat, Olivier, Walzer, Thierry
Vydáno v eLife (2017)

TLR3 and Rig-Like Receptor on Myeloid Dendritic Cells and Rig-Like Receptor on Human NK Cells Are Both Mandatory for Production of IFN-γ in Response to Double-Stranded RNA

Autor Perrot, Ivan, Deauvieau, Florence, Massacrier, Catherine, Hughes, Nicola, Garrone, Pierre, Durand, Isabelle, Demaria, Olivier, Viaud, Nicolas, Gauthier, Laurent, Blery, Mathieu, Bonnefoy-Berard, Nathalie, Morel, Yannis, Tschopp, Jurg, Alexopoulou, Lena, Trinchieri, Giorgio, Paturel, Carine, Caux, Christophe
Vydáno 2010

Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies

Autor Kohrt, Holbrook E., Thielens, Ariane, Marabelle, Aurelien, Sagiv-Barfi, Idit, Sola, Caroline, Chanuc, Fabien, Fuseri, Nicolas, Bonnafous, Cécile, Czerwinski, Debra, Rajapaksa, Amanda, Waller, Erin, Ugolini, Sophie, Vivier, Eric, Romagné, François, Levy, Ronald, Bléry, Mathieu, André, Pascale
Vydáno 2014

Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46

Autor Walzer, Thierry, Bléry, Mathieu, Chaix, Julie, Fuseri, Nicolas, Chasson, Lionel, Robbins, Scott H., Jaeger, Sébastien, André, Pascale, Gauthier, Laurent, Daniel, Laurent, Chemin, Karine, Morel, Yannis, Dalod, Marc, Imbert, Jean, Pierres, Michel, Moretta, Alessandro, Romagné, François, Vivier, Eric
Vydáno 2007

IPH2101, a novel anti-inhibitory KIR antibody, and lenalidomide combine to enhance the natural killer cell versus multiple myeloma effect

Autor Benson, Don M., Bakan, Courtney E., Zhang, Shuhong, Collins, Shauna M., Liang, Jing, Srivastava, Shivani, Hofmeister, Craig C., Efebera, Yvonne, Andre, Pascale, Romagne, Francois, Bléry, Mathieu, Bonnafous, Cécile, Zhang, Jianying, Clever, David, Caligiuri, Michael A., Farag, Sherif S.
Vydáno 2011

Antibody Engineering and Therapeutics: December 8-12, 2013, Huntington Beach, CA

Autor Almagro, Juan Carlos, Gilliland, Gary L, Breden, Felix, Scott, Jamie K, Sok, Devin, Pauthner, Matthias, Reichert, Janice M, Helguera, Gustavo, Andrabi, Raiees, Mabry, Robert, Bléry, Mathieu, Voss, James E, Laurén, Juha, Abuqayyas, Lubna, Barghorn, Stefan, Ben-Jacob, Eshel, Crowe, James E, Huston, James S, Johnston, Stephen Albert, Krauland, Eric, Lund-Johansen, Fridtjof, Marasco, Wayne A, Parren, Paul WHI, Xu, Kai Y
Vydáno 2014

Targeting MICA/B with cytotoxic therapeutic antibodies leads to tumor control

Autor Bléry, Mathieu, Mrabet-Kraiem, Manel, Morel, Ariane, Lhospice, Florence, Bregeon, Delphine, Bonnafous, Cécile, Gauthier, Laurent, Rossi, Benjamin, Remark, Romain, Cornen, Stéphanie, Anceriz, Nadia, Viaud, Nicolas, Trichard, Sylvia, Carpentier, Sabrina, Joulin-Giet, Alix, Grondin, Gwendoline, Liptakova, Veronika, Kim, Younghoon, Daniel, Laurent, Haffner, Aurélie, Macagno, Nicolas, Pouyet, Laurent, Perrot, Ivan, Paturel, Carine, Morel, Yannis, Steinle, Alexander, Romagné, François, Narni-Mancinelli, Emilie, Vivier, Eric
Vydáno v Open Res Eur (2021)

Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells

Autor André, Pascale, Denis, Caroline, Soulas, Caroline, Bourbon-Caillet, Clarisse, Lopez, Julie, Arnoux, Thomas, Bléry, Mathieu, Bonnafous, Cécile, Gauthier, Laurent, Morel, Ariane, Rossi, Benjamin, Remark, Romain, Breso, Violette, Bonnet, Elodie, Habif, Guillaume, Guia, Sophie, Lalanne, Ana Ines, Hoffmann, Caroline, Lantz, Olivier, Fayette, Jérôme, Boyer-Chammard, Agnès, Zerbib, Robert, Dodion, Pierre, Ghadially, Hormas, Jure-Kunkel, Maria, Morel, Yannis, Herbst, Ronald, Narni-Mancinelli, Emilie, Cohen, Roger B., Vivier, Eric
Vydáno v Cell (2018)